These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26730950)

  • 21. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
    Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
    Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion.
    Bale S; Liu T; Li S; Wang Y; Abelson D; Fusco M; Woods VL; Saphire EO
    PLoS Negl Trop Dis; 2011 Nov; 5(11):e1395. PubMed ID: 22102923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.
    Lennemann NJ; Dillard J; Ruggio N; Cooney AL; Schaack GA; Davey RA; Maury W
    J Virol; 2021 Aug; 95(18):e0107321. PubMed ID: 34232742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.
    Brunton B; Rogers K; Phillips EK; Brouillette RB; Bouls R; Butler NS; Maury W
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0006983. PubMed ID: 31242184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.
    Chandran K; Sullivan NJ; Felbor U; Whelan SP; Cunningham JM
    Science; 2005 Jun; 308(5728):1643-5. PubMed ID: 15831716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
    Bo Y; Qiu S; Mulloy RP; Côté M
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-Time Analysis of Individual Ebola Virus Glycoproteins Reveals Pre-Fusion, Entry-Relevant Conformational Dynamics.
    Durham ND; Howard AR; Govindan R; Senjobe F; Fels JM; Diehl WE; Luban J; Chandran K; Munro JB
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31952255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.
    Plegge T; Spiegel M; Krüger N; Nehlmeier I; Winkler M; González Hernández M; Pöhlmann S
    PLoS One; 2019; 14(4):e0214968. PubMed ID: 30973897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Filovirus entry: a novelty in the viral fusion world.
    Hunt CL; Lennemann NJ; Maury W
    Viruses; 2012 Feb; 4(2):258-75. PubMed ID: 22470835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity.
    Lee J; Nyenhuis DA; Nelson EA; Cafiso DS; White JM; Tamm LK
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E7987-E7996. PubMed ID: 28874543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel proteolytic activation of Ebolavirus glycoprotein GP by TMPRSS2 and cathepsin L at an uncharted position can compensate for furin cleavage.
    Bestle D; Bittel L; Werner AD; Kämper L; Dolnik O; Krähling V; Steinmetzer T; Böttcher-Friebertshäuser E
    Virus Res; 2024 Sep; 347():199430. PubMed ID: 38964470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ebola virus glycoprotein interacts with cholesterol to enhance membrane fusion and cell entry.
    Lee J; Kreutzberger AJB; Odongo L; Nelson EA; Nyenhuis DA; Kiessling V; Liang B; Cafiso DS; White JM; Tamm LK
    Nat Struct Mol Biol; 2021 Feb; 28(2):181-189. PubMed ID: 33462517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
    González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.
    Hoffmann M; Crone L; Dietzel E; Paijo J; González-Hernández M; Nehlmeier I; Kalinke U; Becker S; Pöhlmann S
    J Virol; 2017 May; 91(9):. PubMed ID: 28228590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.
    Hood CL; Abraham J; Boyington JC; Leung K; Kwong PD; Nabel GJ
    J Virol; 2010 Mar; 84(6):2972-82. PubMed ID: 20053739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion.
    Fels JM; Bortz RH; Alkutkar T; Mittler E; Jangra RK; Spence JS; Chandran K
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles.
    Nanbo A; Maruyama J; Imai M; Ujie M; Fujioka Y; Nishide S; Takada A; Ohba Y; Kawaoka Y
    PLoS Pathog; 2018 Jan; 14(1):e1006848. PubMed ID: 29338048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2.
    Gregory SM; Harada E; Liang B; Delos SE; White JM; Tamm LK
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11211-6. PubMed ID: 21690393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.
    Nanbo A; Imai M; Watanabe S; Noda T; Takahashi K; Neumann G; Halfmann P; Kawaoka Y
    PLoS Pathog; 2010 Sep; 6(9):e1001121. PubMed ID: 20886108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.
    Johansen LM; Brannan JM; Delos SE; Shoemaker CJ; Stossel A; Lear C; Hoffstrom BG; Dewald LE; Schornberg KL; Scully C; Lehár J; Hensley LE; White JM; Olinger GG
    Sci Transl Med; 2013 Jun; 5(190):190ra79. PubMed ID: 23785035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.